Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
10.46
-0.11 (-1.04%)
Aug 14, 2025, 1:42 PM - Market open
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $799.66 million as of August 14, 2025. Its market cap has decreased by -41.58% in one year.
Market Cap
799.66M
Enterprise Value
374.22M
1-Year Change
-41.58%
Ranking
Category
Stock Price
$10.46
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $799.66M, an increase of 13.57%. That is a compound annual growth rate of 2.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 808.07M | -39.45% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | 1.28B | 81.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 573.79B |
| Johnson & Johnson | 415.80B |
| AbbVie | 350.87B |
| UnitedHealth Group | 235.13B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 227.08B |
| Novo Nordisk | 222.88B |